What Happened?
Silicon Valley, CA-based Synthego Appointed Paul Dabrowski as Chief Executive Officer
About the Company
Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of synthetic guide RNA designed for CRISPR genome editing and research. Synthego`s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.
About the Person
Paul Dabrowski is Chief Executive Officer at Synthego. Previously, Paul held various senior HR leadership roles in the industry.
Info Source
News
Short Profile